JULIUS QUINN: Open Payments
NPI 1073883815 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,578 in 66 payments from 15 companies in 2025. Trend: 2023 $1,807 · 2024 $2,706 · 2025 $1,578
Food & beverage: $1,578
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $308 |
| Corium, LLC | 12 | $197 |
| Alkermes, Inc. | 5 | $186 |
| Teva Pharmaceuticals USA, Inc. | 5 | $177 |
| Vanda Pharmaceuticals Inc. | 4 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $101 |
| Neurocrine BioSciences, Inc. | 5 | $84 |
| Collegium Pharmaceutical, Inc. | 4 | $81 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Supernus Pharmaceuticals, Inc. | 2 | $47 |
Products named: REXULTI, Azstarys, FANAPT, AUSTEDO XR, TRINTELLIX, ABILIFY MAINTENA, ARISTADA, LYBALVI.
Industry payments across KS — which companies pay providers there.
